Patients with PD-L1 tumor expression ≥ 1% had improved PFS compared to those with PD-L1 < 1% (HR: 0.38; 95% CI: 0.21–0.67; p = 0.0003; Figure 4A). The gene discussed is CD274; the disease is neoplasm.